MAP4K inhibition by the CNS penetrant inhibitor famlasertib restrains medulloblastoma dissemination without developmental toxicity
Marc Thomas Schönholzer, Meng-Syuan Lin, Shen Yan…·Martin Baumgartner
This study shows that famlasertib, a MAP4K inhibitor, reduces medulloblastoma cell invasion in vitro and in zebrafish models without causing developmental toxicity.